{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:41:43Z","timestamp":1773351703275,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.ejphar.2016.04.004","type":"journal-article","created":{"date-parts":[[2016,4,6]],"date-time":"2016-04-06T02:15:58Z","timestamp":1459908958000},"page":"83-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias"],"prefix":"10.1016","volume":"781","author":[{"given":"Vasilije","family":"Stambolija","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara Perleta","family":"Stambolija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jadranka Katancic","family":"Holjevac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Murselovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Radonic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktor","family":"Duzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bozidar","family":"Duplancic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordana","family":"Zivanovic-Posilovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danijela","family":"Kolenc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domagoj","family":"Drmic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeljko","family":"Romic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Seiwerth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Predrag","family":"Sikiric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2016.04.004_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.4172\/2155-9880.1000201","article-title":"Mortal furosemide-hypokalemia-disturbances in rats NO-system related. Shorten survival by L-NAME. Therapy benefit with BPC 157 more than with L-arginine","volume":"3","author":"Balenovic","year":"2012","journal-title":"J. Clin. Exp. Cardiol."},{"key":"10.1016\/j.ejphar.2016.04.004_bib2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.regpep.2009.05.008","article-title":"Inhibition of methyldigoxin-induced arrhythmias by pentadecapeptide BPC 157: a relation with NO-system","volume":"156","author":"Balenovic","year":"2009","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2016.04.004_bib3","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.regpep.2012.12.007","article-title":"Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157","volume":"181","author":"Barisic","year":"2013","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2016.04.004_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00000542-198306000-00017","article-title":"Dysrhythmias following muscle relaxant administration in patients receiving digitalis","volume":"58","author":"Bartolone","year":"1983","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2016.04.004_bib5","series-title":"Pharmacology of Neuromuscular Function with Special Reference to Anaesthetic Practice","author":"Bowman","year":"1980"},{"key":"10.1016\/j.ejphar.2016.04.004_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1213\/00000539-198202000-00003","article-title":"Succinylcholine-induced hyperkalemia in the rat following radiation injury to muscle","volume":"61","author":"Cairoli","year":"1982","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2016.04.004_bib8","doi-asserted-by":"crossref","first-page":"19066","DOI":"10.3390\/molecules191119066","article-title":"Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts","volume":"19","author":"Chang","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2016.04.004_bib9","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/0310057X8000800106","article-title":"Suxamethonium fasciculations: a topographical study","volume":"8","author":"Collier","year":"1980","journal-title":"Anaesth. Intensive Care"},{"key":"10.1016\/j.ejphar.2016.04.004_bib10","doi-asserted-by":"crossref","first-page":"E326","DOI":"10.1152\/ajpendo.00345.2001","article-title":"Increased muscle proteolysis after local trauma mainly refl ects macrophage-associated lysosomal proteolysis","volume":"282","author":"Farges","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2016.04.004_bib11","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/jama.1961.73040330027011c","article-title":"The possible dangers of intramuscular succinylcholine","volume":"177","author":"Foldes","year":"1961","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2016.04.004_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.regpep.2009.11.005","article-title":"Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury","volume":"160","author":"Gjurasin","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2016.04.004_bib13","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2147\/DDDT.S82030","article-title":"Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro","volume":"9","author":"Huang","year":"2015","journal-title":"Des. Devel- Ther."},{"key":"10.1016\/j.ejphar.2016.04.004_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.lfs.2011.01.015","article-title":"Pentadecapeptide BPC 157 and its effects on a NSAID toxicity model: diclofenac-induced gastrointestinal, liver, and encephalopathy lesions","volume":"88","author":"Ilic","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2016.04.004_bib15","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejphar.2011.05.038","article-title":"Ibuprofen hepatic encephalopathy, hepatomegaly, gastric lesion and gastric pentadecapeptide BPC 157 in rats","volume":"667","author":"Ilic","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.04.004_bib16","first-page":"241","article-title":"High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736)","volume":"61","author":"Ilic","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.04.004_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/0363546505274714","article-title":"Muscle injuries: biology and treatment","volume":"33","author":"J\u00e4rvinen","year":"2005","journal-title":"Am. J. Sports Med."},{"key":"10.1016\/j.ejphar.2016.04.004_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(99)00486-0","article-title":"Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats","volume":"379","author":"Jelovac","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.04.004_bib19","doi-asserted-by":"crossref","unstructured":"A., Kokot, M., Zlatar, M., Stupnisek, D., Drmic, R., Radic, A., Vcev, S., Seiwerth, P., Sikiric, 2015. NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: reversal by the pentadecapeptide BPC 157 in rats and guinea pigs. European J Pharmacol (pii: S0014-2999(15)30413-1).","DOI":"10.1016\/j.ejphar.2015.12.016"},{"key":"10.1016\/j.ejphar.2016.04.004_bib20","first-page":"597","article-title":"Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability","volume":"64","author":"Klicek","year":"2013","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.04.004_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1254\/jphs.95.19","article-title":"Doxorubicine-congestive heart failure-increased big endothelin-1 plasma concentration: reversal by amlodipine, losartan, and gastric pentadecapeptide BPC157 in rat and mouse","volume":"95","author":"Lovric-Bencic","year":"2004","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2016.04.004_bib22","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/bja\/40.11.901","article-title":"Myoglobinuria following the use of suxamethonium chloride. A case report","volume":"40","author":"Maclaren","year":"1968","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2016.04.004_bib23","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00000542-200601000-00022","article-title":"Succinylcholine-induced hyperkalemia in acquired pathologic states. Etiologic factors and molecular mechanisms","volume":"104","author":"Martyn","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejphar.2016.04.004_bib24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1213\/00000539-196809000-00031","article-title":"Intralingual succinylcholine administration in children: an alternative to intravenous and intramuscular routes?","volume":"47","author":"Mazze","year":"1968","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2016.04.004_bib25","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s00595-007-3706-2","article-title":"Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat","volume":"38","author":"Novinscak","year":"2008","journal-title":"Surg. Today"},{"key":"10.1016\/j.ejphar.2016.04.004_bib26","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/bja\/28.10.470","article-title":"Model of action of neuromuscular blocking agents","volume":"28","author":"Paton","year":"1956","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2016.04.004_bib27","first-page":"2","article-title":"Rocuronium versus succinylcholine for rapid sequence induction intubation","author":"Perry","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ejphar.2016.04.004_bib28","first-page":"BR81","article-title":"Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application","volume":"16","author":"Pevec","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2016.04.004_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF03007477","article-title":"Dose-related effects of succinylcholine on aductor pollicis and masseter muscle in children","volume":"37","author":"Plumley","year":"1990","journal-title":"Can. J. Anaesth."},{"key":"10.1016\/j.ejphar.2016.04.004_bib30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.2174\/13816128113199990421","article-title":"BPC 157 and blood vessels","volume":"20","author":"Seiwerth","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2016.04.004_bib31","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2174\/138161210790945977","article-title":"Revised Robert\u2019s cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator","volume":"16","author":"Sikiric","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2016.04.004_bib32","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0305-4179(03)00004-4","article-title":"Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice","volume":"29","author":"Sikiric","year":"2003","journal-title":"Burns"},{"key":"10.1016\/j.ejphar.2016.04.004_bib33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2174\/092986712803414015","article-title":"Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157","volume":"19","author":"Sikiric","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejphar.2016.04.004_bib34","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2174\/13816128113190990411","article-title":"Stable gastric pentadecapeptide BPC 157-NO-system relation","volume":"20","author":"Sikiric","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2016.04.004_bib35","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.2174\/138161211796196954","article-title":"Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract","volume":"17","author":"Sikiric","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2016.04.004_bib36","first-page":"76","article-title":"Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157","volume":"19","author":"Sikiric","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2016.04.004_bib37","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jor.20089","article-title":"Effective therapy of transected quadriceps muscle in rat: Gastric pentadecapeptide BPC 157","volume":"24","author":"Staresinic","year":"2006","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.ejphar.2016.04.004_bib38","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1748-1716.1955.tb01257.x","article-title":"The effects of acetylcholine, decamethonium and succinylcholine on neuromuscular transmission in the rat","volume":"34","author":"Thesleff","year":"1955","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.ejphar.2016.04.004_bib39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ejphar.2007.05.072","article-title":"Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression","volume":"570","author":"Tkalcevic","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2016.04.004_bib40","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.regpep.2009.11.012","article-title":"Traumatic brain injury in mice and pentadecapeptide BPC 157 effect","volume":"160","author":"Tudor","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejphar.2016.04.004_bib41","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mus.880160211","article-title":"Sustained focal effects of low-dose intramuscular succinylcholine","volume":"16","author":"Walker","year":"1993","journal-title":"Muscle Nerve"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916302072?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299916302072?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:29:21Z","timestamp":1572395361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299916302072"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":40,"alternative-id":["S0014299916302072"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.04.004","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2016.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}